Cyclooxygenase-2 and gastric cancer (Q37946290)

25 August 2017

title

Cyclooxygenase-2 and gastric cancer (English)

1 reference

25 August 2017

Alexandra Thiel

1

1 reference

25 August 2017

Johanna Mrena

series ordinal

2

1 reference

25 August 2017

Ari Ristimäki

series ordinal

3

1 reference

25 August 2017

publication date

1 December 2011

1 reference

Cancer and Metastasis Reviews

25 August 2017

published in

1 reference

25 August 2017

volume

30

1 reference

25 August 2017

issue

3-4

1 reference

25 August 2017

page(s)

387-395

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Epidemiology of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Aspirin and risk for gastric cancer: a population-based case-control study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Cyclooxygenase‐2 and gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Cyclooxygenase-2 expression during carcinogenesis in the human stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Association of cyclooxygenase-2 expression with Hp-cagA infection in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

The relationship between cyclooxygenase-2 expression and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Nonsteroidal anti-inflammatory drugs for treatment of advanced gastric cancer: cyclooxygenase-2 is involved in hepatocyte growth factor mediated tumor development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

The COXIB experience: a look in the rearview mirror

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Molecular characteristics of eight gastric cancer cell lines established in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Human cyclooxygenase-2 cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

21 January 2018

HuR and mRNA stability

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Influences of Helicobacter pylori on cyclooxygenase-2 expression and prostaglandinE2 synthesis in rat gastric epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Helicobacter pylori stimulates host cyclooxygenase-2 gene transcription: critical importance of MEK/ERK-dependent activation of USF1/-2 and CREB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Helicobacter pylori-Induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Helicobacter pylori enhances cyclooxygenase 2 expression via p38MAPK/ATF-2 signaling pathway in MKN45 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

MicroRNA dysregulation in gastric cancer: a new player enters the game

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Expression of 15-PGDH is downregulated by COX-2 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

21 January 2018

Eicosanoids and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

The function and mechanism of COX-2 in angiogenesis of gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Blockade of cholecystokinin-2 receptor and cyclooxygenase-2 synergistically induces cell apoptosis, and inhibits the proliferation of human gastric cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Induction of prostaglandin E2 pathway promotes gastric hamartoma development with suppression of bone morphogenetic protein signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Prostaglandin E2, Wnt, and BMP in gastric tumor mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Prostaglandin E2 Signaling and Bacterial Infection Recruit Tumor-Promoting Macrophages to Mouse Gastric Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Involvement of cyclooxygenase-2 in gastric mucosal hypertrophy in gastrin transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Transgenic cyclooxygenase-2 expression and high salt enhanced susceptibility to chemical-induced gastric cancer development in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and beta-catenin activation in gastric carcinogenesis in N-methyl-N-nitrosourea-treated K19-C2mE transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-011-9312-1

10.1007/S10555-011-9312-1

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference